Tuberculosis

TB is possibly mankind's oldest and most dangerous bacteriological enemy. Estimates of deaths from TB in previous centuries are simply staggering. For instance, estimated deaths from TB in the 19th and 20th centuries amount to ONE BILLION people (more than famine, more than wars, and more than natural disaster) - and for the last fifty years of this period effective TB drugs were available....

TB is still the second largest infectious killer in the world today - endemic to populations cursed with poverty and which endure poor living conditions.

98% of deaths from TB occur in the developing world.  

Normally it kills 70% of those left untreated but  in combination with HIV/AIDS it is even more lethal. In conseqence, rates both of mortality and of latent infection in Africa are the highest in the world, whilst tragically the proper tools for diagnosis and appropriate treatment are the most scarce. Drug supply on the continent is also inconsistent and inadequate.

As if this weren't enough, TB bacteria have an innate propensity for lethal mutation resulting in Drug Resistant TB something which is particularly difficult to diagnose in Africa.

Moxafrica's aims are to investigate as best we possibly can whether moxibustion might have a part to play in the desperate fight against TB in the 21st century - a fight which is known to be being lost in the very places where it simply must be won.

To obtain any sort of understanding of how moxa might truly help, one has to understand the colossal scale of the problem, both epidemiologically and economically.